Gloshell
Ingredients

Ingredient Dictionary

ACRYLOYLOXYETHYL BUTYLCARBAMATE

Molecular structure

Definition

US FDA substance register · UNII I564J85TRD · registered name 2-ACRYLOYLOXYETHYL BUTYLCARBAMATE · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

Holds powders togetherBINDING

Safety & regulatory references

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

More data — names, identifiers, properties, test records, literature

Names & identifiers

ACRYLOYLOXYETHYL BUTYLCARBAMATEINCI2-Propenoic acid, 2-[[(butylamino)carbonyl]oxy]ethyl esterSynonym
CAS No.chemical registry number
63225-53-6
EC No.EU chemical inventory number
264-036-0
EC No.EU chemical inventory number
264-036-0 (I)
DTXSIDUS EPA chemical ID
DTXSID1069798
DTXCIDUS EPA compound ID
DTXCID2043795
IUPAC
2-[(Butylcarbamoyl)oxy]ethyl prop-2-enoate
Molecular formula
C10H17NO4
Molecular weight
215.249 g/mol

Measured properties

Appearance
Liquid · liquid
Melting/freezing point
-14.01 ℃(est.)
Initial boiling point and range
258.23 ℃(est.)
Vapour pressure
0.0175 ㎜Hg (1.75E-02 mmHg est.)
Water solubility
1027 ㎎/ℓ (est.)
n-Octanol/water partition coefficient (Kow)
1.82 (est.)

Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.

Source: PubChem · KOSHA safety data sheets (Korea)

What products actually use it for

What the 6 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Solvent2
  • Photosensitive agent2
  • Monomers1
  • Binder1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

1 skin studies and 1 eye studies are on record.

Classed as highly irritating1

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 2 studies
  • High Frequency of Sensitization
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) adopted in 2002
  • Studies Indicate No Significant Irritation
    eye irritation: in vitro / ex vivo · Screening · OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants) [before 26 July 2013] according to

Source: US EPA CompTox dashboard

Linked databases 11